The Bulletin
The Times


.

Zuellig Pharma and Institut AllergoSan sign 10-year regional partnership to bring leading probiotic brand OMNi-BiOTiC® to key markets in Asia

  • Written by The Bulletin

New agreement marks major milestone for Zuellig Pharma as it focuses on expanding its consumer healthcare segment, and for Institut AllergoSan as it expands its global presence

SINGAPORE - Media OutReach Newswire - 19 July 2024 - Zuellig Pharma, a leading healthcare solutions company in Asia, today announced that it has signed a 10-year commercialisation partnership with Austria-based Institut AllergoSan, a research and development company that specialises in products made from natural substances such as probiotic bacteria, plant extracts and minerals.

Read more: Zuellig Pharma and Institut AllergoSan sign 10-year regional partnership to bring leading...

hacklink hack forum hacklink film izle hacklink testjojobetjojobetcasibomagb99galabetbetofficebetofficeclassifica casino non aamsKavbetKavbet girişNon Gamstop Sitesbetasus girişcasibombedava sorgudizipalonline casinos australiaonline casinosonline casino australianon GamStop casinojojobetjojobetz library frjojobetjojobetjojobetcasibomdeneme bonusu veren sitelermeritkingpusulabet